Market Overview

Morning Market Movers

Related OMED
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
OncoMed Begins Patient Dosing In Phase 2 Clinical Trial Of Tarextumab In Small Cell Lung Cancer
Related CELG
These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals
Phase II Data for Apremilast in Behçet's Disease Published in The New England Journal of Medicine
How To Invest In ETFs: Tips To Trade Top Market Trends (Investor's Business Daily)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (CELG + CNAT)

Around the Web, We're Loving...

Get Benzinga's Newsletters